Finally, a non-dopaminergic antipsychotic (xanomeline-trospium) for treatment of schizophrenia: Significance and learnings

Asian J Psychiatr. 2024 Dec:102:104320. doi: 10.1016/j.ajp.2024.104320. Epub 2024 Nov 19.

Author

Affiliation

¹ Department of Psychiatry, WMU Homer Stryker School of Medicine, Kalamazoo, MI, United States. Electronic address: rajiv.tandon@wmed.edu.

PMID: 39577134
DOI: 10.1016/j.ajp.2024.104320

No abstract available

Publication types

Editorial